MONTREAL — An American company that signed a deal with the federal government to produce COVID\u002D19 vaccines in Montreal has warned investors it could go out of…
The company, which has more than $1.3 billion in cash in hand, is counting on its ability to develop and sell an updated COVID-19 vaccine next fall and is cutting costs, Kelly told investors.
However, on an NRC website last updated in December, the federal science and technology agency said it is still working on the “technology transfer” required to produce the vaccine.Article content“Novavax continues to make progress towards establishing local manufacturing capabilities in partnership with NRC/, with manufacturing of process performance qualification batches expected to begin in early 2023,” the company said.
“We’re continuing to explore options with potential collaborators on producing vaccines and other biologics at the facility on its second production line,” Christine Jodoin, the vice-president of strategic initiatives at the NRC, wrote in an email.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Company planning to make COVID-19 vaccine in Canada could go out of businessAn American company that signed a deal with the federal government to produce COVID-19 vaccines in Montreal is warning investors it could go out of business within the year.
Lire la suite »
Everything Coming to Netflix Canada in March 2023 | Elle CanadaFrom season 2 of nextinfashion to MurderMystery 2 starring JenniferAniston and AdamSandler, here's everything coming to netflix Canada this month.
Lire la suite »
Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trialsFor the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials. Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug 'significantly reduces' viral load and inflammation in the lungs.
Lire la suite »
Drug maker AstraZeneca to expand Canadian operations, hire hundreds of workersThe Canadian government is not helping fund the company’s $500\u002Dmillion expansion in Canada.
Lire la suite »
China should allow further investigation into COVID-19 origins, says Canada’s health ministerJean-Yves Duclos told the Star Wednesday evidence is ‘mixed’ that a lab leak started the global pandemic.
Lire la suite »
U.S. company that made deal to produce COVID vaccine in Canada warns it could go out of businessNovavax executives told investors that there is uncertainty surrounding the company\u0027s ability to fund operations as the COVID\u002D19 vaccine market changes
Lire la suite »